Literature DB >> 7226958

Temporary left ventricular assistance in acute myocardial infarction and cardiogenic shock: rationale and criteria for utilization.

W E Pae, W S Pierce.   

Abstract

Left ventricular bypass may offer significantly better salvage of left ventricular myocardium in patients who remain hemodynamically unstable in spite of aggressive medical therapy and intra-aortic balloon support. Indeed, those 25 percent of patients refractory to intra-aortic balloon pumping may be salvageable with the prompt institution of left ventricular pumping assistance; however, just as early initiation of intra-aortic balloon pumping is critical, the early identification of balloon pumping failures and the institution of left ventricular bypass pumping may lead to a lower incidence of patients dependent on circulatory assistance and a higher rate of primary weaning. The results of left ventricular pumping assistance may indeed be totally different than those achieved with the intra-aortic balloon pump under these same conditions, because of the marked left ventricular unloading and hence the greater reduction in myocardial consumption of oxygen. The self-perpetuating cycle of progressive irreversible cardiac damage and shock may be broken, resulting in salvage of critical myocardial mass. Thus, cases of pumping dependence may be uncommon. There is also reason to believe that the heart without anatomically correctable lesions might function satisfactorily, but with a low cardiac reserve. Successful clinical application of left ventricular pumping assistance and subsequent analysis of therapeutic results demand a carefully devised protocol. This must be based on knowledge of the natural history of the disease and the results of previous sound clinical and experimental studies.

Entities:  

Mesh:

Year:  1981        PMID: 7226958     DOI: 10.1378/chest.79.6.692

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system.

Authors:  O H Frazier; E A Rose; P McCarthy; N A Burton; A Tector; H Levin; H L Kayne; V L Poirier; K A Dasse
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

2.  Experience with the Pierce-Donachy ventricular assist device in postcardiotomy patients with cardiogenic shock.

Authors:  D G Pennington; L D Samuels; G Williams; D Palmer; M T Swartz; J E Codd; J P Merjavy; D Lagunoff; J H Joist
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

Review 3.  The interface between monitoring and physiology at the bedside.

Authors:  Eliezer L Bose; Marilyn Hravnak; Michael R Pinsky
Journal:  Crit Care Clin       Date:  2015-01       Impact factor: 3.598

4.  Percutaneous ventricular assist device placement during active cardiopulmonary resuscitation for severe refractory cardiogenic shock after acute myocardial infarction.

Authors:  Gary M Idelchik; Pranav Loyalka; Biswajit Kar
Journal:  Tex Heart Inst J       Date:  2007

5.  Transradial unprotected left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device.

Authors:  H H Minden; H Lehmann; J Meyhöfer; C Butter
Journal:  Clin Res Cardiol       Date:  2006-03-21       Impact factor: 6.138

6.  Percutaneous left ventricular assist device vs. intra-aortic balloon pump in patients with severe left ventricular dysfunction undergoing cardiovascular intervention: A meta-analysis.

Authors:  Fang-Bin Hu; Lian-Qun Cui
Journal:  Chronic Dis Transl Med       Date:  2018-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.